Latest Breaking News On - Akihiro tsujimura - Page 1 : comparemela.com

Mitsubishi Chemical : Announcement of launch of SGLT2 inhibitor CANAGLU OD Tablets ～Adoption of Environmentally Friendly Biomass-plastic PTP Sheets～NEW

Mitsubishi Chemical : Announcement of launch of SGLT2 inhibitor CANAGLU OD Tablets ～Adoption of Environmentally Friendly Biomass-plastic PTP Sheets～NEW
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Chuo kuAkihiro tsujimuraMitsubishi tanabe pharma corporation head officeCommunications divisionOsaka communications departmentMitsubishi chemical group corporationMitsubishi chemical corporationMitsubishi chemical groupEnvironmentally friendly biomass plasticTanabe pharma corporationHead officeCanagliflozin hydratePress through packMitsubishi chemical

Mitsubishi Chemical : Announcement of Executive Personnel Changes of Mitsubishi Chemical Group CorporationNEW

May 20, 2024 Announcement of Executive Personnel Changes of Mitsubishi Chemical Group Corporation 1. Change in Charge.

Isao yanoGlenn fredricksonTatsumi yamadaManabu chikumotoToshiya katsuragiSatoshi wakabayashiFranck ruelYasuo shimodairaGeoffrey coatesYoshio akahaneMinoru kidaTakayuki hashimotoYuji ichimuraNobuo fukudaKiyomi kikuchiJin iida

Mitsubishi Chemical : Announcement of Approval Submission and Marketing Alliance in Japan for Tirzepatide as a Drug for Obesity DiseaseNEW

Mitsubishi Chemical : Announcement of Approval Submission and Marketing Alliance in Japan for Tirzepatide as a Drug for Obesity DiseaseNEW
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Tanabe pharmaSimone thomsenAkihiro tsujimuraMitsubishi tanabe pharma corporationMarketing allianceMinistry of healthPress releaseApproval submissionObesity diseaseRepresentative directorEli lilly japanMitsubishi tanabe pharmaLilly japanSubcutaneous injection

Kyowa Kirin : Received Approval for Calcimimetics Agent ORKEDIA® TABLETS 4mg in Japan (221KB) -Today at 03:36 am

Kyowa Kirin Received Approval for Calcimimetics Agent ORKEDIA® TABLETS 4mg in Japan Tokyo, Japan, August 30, 2023 Kyowa Kirin Co., Ltd. .

Tanabe pharmaMasashi miyamotoAkihiro tsujimuraKyowa kirin co ltdMitsubishi tanabe pharma corporation representativeMinistry of healthKyowa kirin groupKyowa kirin received approvalCalcimimetics agentKyowa kirinMitsubishi tanabe pharma corporationRepresentative directorMitsubishi tanabe pharma

AnGes : filed for approval of its HGF gene therapy product Collategene® for the first time since the introduction of the conditional/time-limited authorization system for regenerative medicine products

May 31, 2023 Company Name: AnGes Inc. Presentative: Ei Yamada, President & CEO . | May 31, 2023

United statesChuo kuAkihiro tsujimuraAnges incMinistry of healthMitsubishi tanabe pharma corporation chemical groupAir groupMitsubishi tanabe pharma corporationMitsubishi tanabe pharma corporation head officeCorporate communicationsAnges head officeMitsubishi chemical groupOsaka corporate communications deptAffairs lawCompany nameMarketing approval application